Under a new tuberculosis (TB) diagnosis strategy, people considered to be at high risk of TB are offered molecular TB tests, even if they do not have any symptoms. A landmark study in 2020 showed that such a strategy can help diagnose more people more quickly. Now, early indications are that it also works in the real world and South Africa’s lab service says they can cope with the increased demand. Tiyese Jeranji reports.
It is time to engage communities through community healthcare workers and to leverage COVID-19 innovations to advance the urgent need for high-quality, person-centred tuberculosis (TB) care for all, argue authors from leading TB advocacy organisation TB Proof.